Your browser doesn't support javascript.
loading
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma.
Zhang, Hai-Feng; Delaidelli, Alberto; Javed, Sumreen; Turgu, Busra; Morrison, Taylor; Hughes, Christopher S; Yang, Xiaqiu; Pachva, Manideep; Lizardo, Michael M; Singh, Gurdeep; Hoffmann, Jennifer; Huang, Yue Zhou; Patel, Khushbu; Shraim, Rawan; Kung, Sonia H Y; Morin, Gregg B; Aparicio, Samuel; Martinez, Daniel; Maris, John M; Bosse, Kristopher R; Williams, Karla C; Sorensen, Poul H.
Affiliation
  • Zhang HF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Delaidelli A; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Javed S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Turgu B; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Morrison T; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
  • Hughes CS; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Yang X; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Pachva M; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Lizardo MM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Singh G; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Hoffmann J; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Huang YZ; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Patel K; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Shraim R; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T1Z4, Canada.
  • Kung SHY; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Morin GB; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Aparicio S; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Martinez D; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
  • Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Bosse KR; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Williams KC; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Sorensen PH; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Sci Adv ; 9(34): eadg6693, 2023 08 25.
Article in En | MEDLINE | ID: mdl-37611092
ABSTRACT
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to MNA+ NB remains poorly understood. Here, we identify that GREB1, a transcription factor encoding gene neighboring the MYCN locus, is frequently coexpressed with MYCN and promotes cell survival in MNA+ NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B (MYO1B) as being highly expressed in MNA+ NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in MNA+ NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in MNA+ NB and independently of MYCN.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Secretome / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Secretome / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country:
...